PATENT CLAIM ANALYSIS

Application Number: 16066962
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "450000"]

Abstract:
The present disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein comprise administering a cationic liposomal formulation containing one or more cationic lipids and a taxane to a subject in need thereof. The methods also include administering one or more non-liposomal formulations including one or more active agents.

Claim (Index 6):
The method of  claim 1 , wherein the cationic liposomal formulation is administered first; the non-liposomal formulation is administered second; and the further active agent is administered third.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.475
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13430393', '14833442', '11919700', '14959497', '12293039']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7954244977149019
- 35 USC 102 Novelty (BERT): 0.55453929448989
- Combined Prediction Score: 0.7713359773924007
- Mean Citation Score: 404.892876
- Max Citation Score: 432.44186
- Similarity Product: 341.6459616601564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test